Cecilia Correia

Porto, 4200072, Portugal

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Multiple Myeloma Laboratory Diagnostics Made Simple: Practical Insights and Key Recommendations.

Multiple Myeloma Laboratory Diagnostics Made Simple: Practical Insights and Key Recommendations.

Journal: Journal of clinical medicine
Published: September 01, 2025

Diagnosis and Laboratory Follow-Up of Patients with Multiple Myeloma: Guidelines from the Portuguese Multiple Myeloma Group

Diagnosis and Laboratory Follow-Up of Patients with Multiple Myeloma: Guidelines from the Portuguese Multiple Myeloma Group

Journal: Acta medica portuguesa
Published: January 20, 2025

Discontinuation of tyrosine kinase inhibitors in CML patients in real-world clinical practice at a single institution.

Discontinuation of tyrosine kinase inhibitors in CML patients in real-world clinical practice at a single institution.

Journal: BMC cancer
Published: July 12, 2018

Ponatinib induces a sustained deep molecular response in a chronic myeloid leukaemia patient with an early relapse with a T315I mutation following allogeneic hematopoietic stem cell transplantation: a case report.

Ponatinib induces a sustained deep molecular response in a chronic myeloid leukaemia patient with an early relapse with a T315I mutation following allogeneic hematopoietic stem cell transplantation: a case report.

Journal: BMC cancer
Published: June 15, 2018

Classical fragile-X phenotype in a female infant disclosed by comprehensive genomic studies.

Classical fragile-X phenotype in a female infant disclosed by comprehensive genomic studies.

Journal: BMC medical genetics
Published: October 16, 2017

NCOA2 is a candidate target gene of 8q gain associated with clinically aggressive prostate cancer.

NCOA2 is a candidate target gene of 8q gain associated with clinically aggressive prostate cancer.

Journal: Genes, chromosomes & cancer
Published: October 01, 2015

POU1F1 is a novel fusion partner of NUP98 in acute myeloid leukemia with t(3;11)(p11;p15).

POU1F1 is a novel fusion partner of NUP98 in acute myeloid leukemia with t(3;11)(p11;p15).

Journal: Molecular cancer
Published: September 12, 2012

Genetic and clinical characterization of 45 acute leukemia patients with MLL gene rearrangements from a single institution.

Genetic and clinical characterization of 45 acute leukemia patients with MLL gene rearrangements from a single institution.

Journal: Molecular oncology
Published: May 14, 2012
Showing 1-8 of 8

Last Updated: 09/26/2026